Correlation Between Nuvalent and Pliant Therapeutics
Can any of the company-specific risk be diversified away by investing in both Nuvalent and Pliant Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvalent and Pliant Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvalent and Pliant Therapeutics, you can compare the effects of market volatilities on Nuvalent and Pliant Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvalent with a short position of Pliant Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvalent and Pliant Therapeutics.
Diversification Opportunities for Nuvalent and Pliant Therapeutics
0.59 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Nuvalent and Pliant is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Nuvalent and Pliant Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pliant Therapeutics and Nuvalent is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvalent are associated (or correlated) with Pliant Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pliant Therapeutics has no effect on the direction of Nuvalent i.e., Nuvalent and Pliant Therapeutics go up and down completely randomly.
Pair Corralation between Nuvalent and Pliant Therapeutics
Given the investment horizon of 90 days Nuvalent is expected to generate 0.84 times more return on investment than Pliant Therapeutics. However, Nuvalent is 1.18 times less risky than Pliant Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Pliant Therapeutics is currently generating about -0.02 per unit of risk. If you would invest 7,423 in Nuvalent on November 9, 2024 and sell it today you would earn a total of 1,247 from holding Nuvalent or generate 16.8% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Nuvalent vs. Pliant Therapeutics
Performance |
| Timeline |
| Nuvalent |
| Pliant Therapeutics |
Nuvalent and Pliant Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nuvalent and Pliant Therapeutics
The main advantage of trading using opposite Nuvalent and Pliant Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvalent position performs unexpectedly, Pliant Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pliant Therapeutics will offset losses from the drop in Pliant Therapeutics' long position.| Nuvalent vs. Arcellx | Nuvalent vs. Vaxcyte | Nuvalent vs. Viridian Therapeutics | Nuvalent vs. Ventyx Biosciences |
| Pliant Therapeutics vs. Relay Therapeutics | Pliant Therapeutics vs. Stoke Therapeutics | Pliant Therapeutics vs. Black Diamond Therapeutics | Pliant Therapeutics vs. Arvinas |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |